Inamed is an international Contract Research Organization (CRO) providing its clients with the full range of services, required for the planning, conduct and evaluation of clinical trials throughout all phases, for nearly two decades. Founded in 1998, Inamed is located in the periphery of Munich.
Complementing our solid experience in conducting clinical trials in various indications, Inamed's team of inhalation and clinical experts provides our sponsors with a unique spectrum of services. Besides our clinical trial operations and state-of the-art, in-house clinical pharmacology unit with 24 beds (+6 intensive monitoring beds), Inamed performs specialized studies such a flow-profile investigations for inhalation devices.
Our studies deliver the highest quality data and can enhance your clinical trials and development projects for drugs and inhalation devices. Inamed offers an opportunity for sponsors to get their products to market more successfully.
Ranging from dedicated respiratory clinical trials, such as Phase I-IV with inhaled compounds or inhalation devices, up to specialized clinical trials such as Flow-Profile studies, Inamed provides the full range of services.Read more
At its own in-house Clinical Pharmacology Unit, Inamed is prepared to conduct all kinds of early phase clinical trials, ranging from First-in-Man studies up to studies with complex endpoints.Read more
The measurement of inhalation flow profiles of subjects inhaling through dry powder inhalers (DPIs) has been coming more and more into focus lately and is, for instance, currently requested by the EMA and FDA as part of the in-vivo device characterization process. In order to thoroughly understand the technical and device specific aspects during inhalation, a comparison of flow profile measurements is considered necessary. Read more
From Nov 16 – 18, 2017 the 20th Annual Meeting of the German Cystic Fibrosis Society (Muko e.V.) took place. During this conference Dominik Kappeler and Irene Heimbeck presented a poster with promising results of a First-in-Patient study, involving 24 CF patients, which has been conducted at Inamed’s Clinical Unit. Read more